Riskpilot← Back to searchSign inGet full accessDoctorad AB
ABActiveOrg 5568355571Bögatan 22Hospital activities · NACE 8610Est. 20101 employees
Revenue 2025
SEK 3,1M
0% vs 2024
EBITDA margin
62.8%
+9% vs 2024
Equity ratio
77.1%
Financial strength
Net profit 2025
SEK 1,9M
+60% vs 2024
| Revenue | SEK 3,1M | +0% |
| EBITDA | SEK 2M | +9% |
| Net profit | SEK 1,9M | +60% |
| Total assets | SEK 12,9M | +11% |
| Equity | SEK 10M | +18% |
| Employees | 1 | — |
Legal name
Doctorad AB
Org number
5568355571
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
23 december 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska idka uthyrning av läkare med specialistkompetens och därmed förenlig verksamhet.
Address
Bögatan 22
Phone
+46733180928
Email
agwysocka@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 563 | 3 568 | 2 977 | 3 111 | 3 108 |
| Staff expenses | — | −797 | −1 016 | −917 | −928 |
| EBITDA | 1 943 | 2 635 | 1 687 | 1 791 | 1 952 |
| Depreciation & amort. | −139 | −139 | −139 | −139 | — |
| EBIT | 1 804 | 2 496 | 1 548 | 1 652 | 1 952 |
| Net financials | — | 15 | 84 | 26 | 3 |
| Profit before tax | 1 354 | 1 891 | 1 557 | 1 548 | 2 455 |
| Tax | −280 | −393 | −334 | −337 | −520 |
| Net profit | 1 074 | 1 498 | 1 224 | 1 212 | 1 934 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 403 | 10 603 | 10 996 | 11 632 | 12 925 |
| Equity | 5 102 | 6 401 | 7 624 | 8 436 | 9 970 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 780 | 2 062 | 1 157 | 851 | 1 109 |
| Total debt | 1 780 | 2 062 | 1 157 | 851 | 1 109 |
EBITDA margin
62.8%
This company
15.8%
Market median
+297% vs market
20212025
Equity ratio
77.1%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
19.4%
This company
18.4%
Market median
+5% vs market
20212025
Net profit margin
62.2%
This company
8.1%
Market median
+668% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doctorad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Grazyna Krantz Wysocka | Board of Directors | 0 companies |
| Hans Christian Gunnar Krantz | Deputy Board Member | 0 companies |